Chidamide
KEPIDA-2
Phase 2 small_molecule active
Quick answer
Chidamide for Relapsed or Refractory Peripheral T-cell Lymphoma is a Phase 2 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Relapsed or Refractory Peripheral T-cell Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active